REQUEST A DEMO
Total
USD $0.00
Search more companies

Cytomed Therapeutics Ltd. (Singapore)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Cytomed Therapeutics Ltd. Profile Updated: July 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

CytoMed Therapeutics Limited is a biopharmaceutical company that develops novel cell-based immunotherapies for the treatment of various cancers. The Company is headquartered in Singapore and conducts its operations domestically and in Malaysia.
History:
2018 - The Company incorporated on March 8, in the Republic of Singapore.
2020 to 2021 - The company has an exclusive, worldwide license to use the CAR-γδ T cell technology, which was granted a patent in the US and China.
2023 - January 19, the Company had converted to a public limited company and the name of the Company has changed from “CytoMed Therapeutics Pte. Ltd.” to “CytoMed Therapeutics Limited”
- The Company listed on April 14, at NASDAQ with stockex GDTC

Headquarters
08-22 One Commonwealth, 1 Commonwealth Lane
Singapore; Singapore; Postal Code: 149544

Contact Details: Purchase the Cytomed Therapeutics Ltd. report to view the information.

Website: http://www.cytomed.sg.

Basic Information
Total Employees:
Purchase the Cytomed Therapeutics Ltd. report to view the information.
Outstanding Shares:
Purchase the Cytomed Therapeutics Ltd. report to view the information.
Financial Auditors:
Purchase the Cytomed Therapeutics Ltd. report to view the information.
Incorporation Date:
2018
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Chief Operating Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
40.33%
Purchase this report to view the information.
11.59%
Purchase this report to view the information.
7.66%
Purchase this report to view the information.
5.11%
Subsidiaries
Advance Cancer Centre Pte Ltd
100%
Ipsc Depository Sdn Bhd (Malaysia)
100%
Ipscbank Pte Ltd
100%
Company Performance
Financial values in the chart are available after Cytomed Therapeutics Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Total operating revenue
-6.44%
Operating profit (EBIT)
44.06%
EBITDA
31.87%
Net Profit (Loss) for the Period
49.54%
Total assets
-21.6%
Total equity
-22.84%
Return on Equity (ROE)
5.67%
Debt to Equity Ratio
0.63%
Quick Ratio
-14.88%
Cash Ratio
-15.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?